Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.

Milota, Tomás; Malcová, Hana; Strízová, Zuzana; Cebecauerová, Dita; Horváth, Rudolf

Milota, Tomás; Malcová, Hana; Strízová, Zuzana; Cebecauerová, Dita; Horváth, Rudolf.

Cas Lek Cesk ; 161(1): 3-10, 2022.

Article in En | MEDLINE | ID: mdl-35354288

Subject(s)

Cryopyrin-Associated Periodic Syndromes; Hereditary Autoinflammatory Diseases; Mevalonate Kinase Deficiency; Cryopyrin-Associated Periodic Syndromes/drug therapy; Hereditary Autoinflammatory Diseases/drug therapy; Humans; Interleukin Inhibitors; Interleukin-1/therapeutic use; Mevalonate Kinase Deficiency/drug therapy

Key words

anakinra; canakinumab; cardiovascular disease; interleukin 1; monogenic periodic fever syndromes; rilonacept

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Mevalonate Kinase Deficiency / Hereditary Autoinflammatory Diseases / Cryopyrin-Associated Periodic Syndromes Limits: Humans Language: En Journal: Cas Lek Cesk Year: 2022 Type: Article

Search on Google

XML

PubMed Links